Latest

Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆

Search Results

Found 3 results for "Sreepriya Prasannan" across articles, medicines, trials, companies and the glossary

The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences

The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences

MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.

High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma

High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma

A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.

Inside Fierce Summit 2026: A Founder's Perspective on Building CareSight and Empowering Women in Tech

Inside Fierce Summit 2026: A Founder's Perspective on Building CareSight and Empowering Women in Tech

Our founder, Sreepriya Prasannan, shares her experience from the invitation-only Fierce Summit 2026 at Dogpatch Labs, Dublin-from high-impact VC mentoring sessions to the power of hallway conversations with fellow women tech founders.